Aryl-Alkylamines And Heteroaryl-Alkylamines As Protein Kinase Inhibitors

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20100210617A1
SERIAL NO

11993835

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

each are hydrogen or a substituent as defined in the claims

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ASTRAZENECA ABSE-151 85 SODERTALJE
CANCER RESEARCH TECHNOLOGY LIMITEDANGEL BUILDING 407 ST JOHN STREET LONDON EC1V 4AD
ASTEX THERAPEUTICS LIMITED436 CAMBRIDGE SCIENCE PARK MILTON ROAD CAMBRIDGE CB4 0QA
THE INSTITUTE OF CANCER RESEARCH ROYAL CANCER HOSPITALLONDON SW7 3RP

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Downham, Robert Newmarket, GB 25 140
Hamlett, Christopher Cambridge, GB 4 3
Howard, Steven Cambridge, GB 78 720
Luke, Richard William Arthur Cheshire, GB 25 170
Sore, Hannah Fiona Cambridge, GB 11 102
Verdonk, Marinus Leendert Burwell, GB 13 119
Walker, David Winter Linton, GB 25 158
Woodhead, Steven John Cambridge, GB 32 655

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation